Mayo Clinic startup uses AI to discover new medicines - Pharmaphorum

Leading US hospital Mayo Clinic has unveiled a new startup company that uses artificial intelligence to discover novel treatments. Launched in partnership with American tech company nference, Qrativ (pronounced'curative') combines Mayo Clinic's medical expertise and clinical data with nference's AI platform nferX. The deep learning-driven AI sifts through masses of medical literature and clinical data to uncover insights into disease and will form the basis of Qrativ's Darwin.ai These insights can then be used to guide the development of new drugs. Initially, Qrativ will focus on drug repurposing for rare diseases and highly targeted patient populations.